After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen

This undated image made from video provided by Eisai Co., Ltd., shows Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies, at Eisai's Kawashima plant in Kakamigahara city, Gifu Prefecture, central Japan. Japan's health ministry has approved Leqembi, the first drug for the treatment of the disease in a country with a rapidly aging population. Leqembi was developed by Japanese drugmaker Eisai and U.S. biotechnology firm Biogen.

Leqembi is for patients with mild dementia and other symptoms in the early stages of Alzheimer's disease, and the first medicine that can modestly slow their cognitive decline.Prime Minister Fumio Kishida, who announced Japan's approval of Leqembi on Monday, called it “a breakthrough” and said that the “treatment of dementia has now entered a new era.”

According to the health ministry, Japan's number of dementia patients who are 65 years of age or older will rise to 7 million in 2025, from the current 6 million.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

After US approval, Japan OKs Leqembi, its first Alzheimer's drug, developed by Eisai and BiogenJapan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies.
Source: AP - 🏆 728. / 51 Read more »

After US approval, Japan approves Leqembi, its first Alzheimer's drugJapan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies.
Source: nbcsandiego - 🏆 524. / 51 Read more »

After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and BiogenJapan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies.
Source: ksatnews - 🏆 442. / 53 Read more »

After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and BiogenJapan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies.
Source: KPRC2 - 🏆 80. / 68 Read more »

After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and BiogenJapan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies.
Source: wjxt4 - 🏆 246. / 63 Read more »